TAIKO PHARMACEUTICAL CO.,LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 399 JPY | +1.79% |
|
+0.25% | +31.68% |
ETFs positioned on Taiko Pharmaceutical Co.,Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.04% | 14 M€ | +11.34% | ||
| 0.00% | 17 M€ | +18.02% | - | |
| 0.00% | 138,841 M€ | +17.05% | ||
| 0.00% | 19,753 M€ | +15.91% | - | |
| 0.00% | 32 M€ | +4.26% | - |
TAIKO PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company. The Company is engaged in three business segments. The Pharmaceutical Product segment is engaged in the manufacturing, sales and export of gastrointestinal drugs under the name SEIROGAN, SEIROGAN TOI-A (sugar coated tablet) and PISHUT. The Infection Control segment is engaged in the planning, development and sales of infection control products, which apply proprietary technique regarding chlorine dioxide gas. The Others segment is engaged in the manufacturing and sales of bath liquid, soap and gardening pyroligneous acid.
Sector
Pharmaceuticals
Calendar
09/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +31.68% | 123M | |
| +18.66% | 42.12B | |
| +23.31% | 21.72B | |
| +20.33% | 15.75B | |
| +20.71% | 14.89B | |
| +56.75% | 13.06B | |
| -0.05% | 6.79B | |
| -12.68% | 6.3B | |
| +20.03% | 6.05B | |
| -8.87% | 5.73B |
- Stock Market
- Equities
- 4574 Stock
- Funds and ETFs Taiko Pharmaceutical Co.,Ltd.
